Texas Attorney General Sues Tylenol Makers Regarding Autism Claims
The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, asserting the companies withheld potential risks that the pain reliever created to pediatric neurological development.
This legal action arrives four weeks after Donald Trump advocated an unproven link between taking Tylenol - referred to as acetaminophen - throughout gestation and autism spectrum disorder in young ones.
Paxton is suing J&J, which once produced the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which now manufacturers it.
In a declaration, he said they "betrayed America by gaining financially from pain and marketing drugs without regard for the risks."
The manufacturer asserts there is lacking scientific proof linking Tylenol to autism.
"These companies lied for decades, intentionally threatening countless individuals to increase profits," Paxton, a Republican, declared.
The manufacturer said in a statement that it was "very worried by the spread of false claims on the security of paracetamol and the likely effects that could have on the welfare of US mothers and children."
On its website, the company also stated it had "consistently assessed the applicable studies and there is insufficient valid information that shows a verified association between taking paracetamol and autism."
Groups representing doctors and healthcare providers concur.
The leading OB-GYN organization has declared paracetamol - the key substance in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can pose significant medical dangers if not addressed.
"In over twenty years of investigation on the utilization of paracetamol in gestation, zero credible investigations has successfully concluded that the consumption of acetaminophen in any trimester of gestation causes brain development issues in young ones," the association commented.
The lawsuit mentions latest statements from the Trump administration in arguing the medication is reportedly hazardous.
In recent weeks, the former president generated worry from public health officials when he instructed pregnant women to "resist strongly" not to take Tylenol when sick.
The US Food and Drug Administration then issued a notice that medical professionals should contemplate reducing the consumption of Tylenol, while also stating that "a causal relationship" between the drug and autism in minors has remains unverified.
The Health Department head RFK Jr, who supervises the Food and Drug Administration, had vowed in spring to initiate "extensive scientific investigation" that would determine the cause of autism spectrum disorder in a limited time.
But experts advised that finding a unique factor of autism - considered by experts to be the outcome of a complex mix of genetic and external influences - would prove challenging.
Autism is a category of lifelong neurodivergence and condition that influences how individuals perceive and engage with the environment, and is identified using medical professional evaluations.
In his court filing, the attorney general - a Trump ally who is seeking the Senate - asserts Kenvue and J&J "willfully ignored and tried to quiet the evidence" around paracetamol and autism.
This legal action attempts to require the corporations "eliminate any marketing or advertising" that states Tylenol is secure for women during pregnancy.
This legal action parallels the complaints of a collection of guardians of minors with autism spectrum disorder and ADHD who sued the producers of Tylenol in recently.
A federal judge rejected the legal action, stating studies from the parents' expert witnesses was lacking definitive proof.